<DOC>
	<DOCNO>NCT02347358</DOCNO>
	<brief_summary>This study test hypothesis temporary implantation JRecanTM blood flow recanalisation device within 6.5 hour symptom onset acute ischemic stroke due major intracranial artery occlusion follow IV r-tPA provide great rate early successful recanalisation treatment IV r-tPA alone .</brief_summary>
	<brief_title>Mechanical Opening Device Implantation Following Intravenous r-tPA Recanalization Acute Ischemic Stroke</brief_title>
	<detailed_description />
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Plasminogen</mesh_term>
	<mesh_term>Tissue Plasminogen Activator</mesh_term>
	<criteria>1 . Age 18 75 2 . Clinical presentation consistent acute ischemic stroke 3 . NIHSS ≥ 8 &lt; 30 time randomization 4 . Initiation correct IV tPA dose treatment within 4.5 hour onset stroke symptom ( onset time define last time patient witness baseline ) 5 . Complement catheter angiography within 6.5 hour onset stroke symptom 6 . Thrombolysis myocardial Infarction ( TIMI ) 01 flow intracranial internal carotid artery , M1 segment MCA , basilar artery , intracranial vertebral artery contralaterally chronic intracranial vertebral artery occlusion confirm catheter angiography 7 . The acute occlusion lesion accessible JRecanTM blood flow recanalisation device 8 . Functional independence time stroke ( Modified Rankin Score ≤ 1 ) 9 . Subject subject 's legally authorize representative sign date Informed Consent Form accord country regulation , ethic committee requirement . 10 . Subject willing conduct protocolrequired followup visit . 1 . NIHSS &lt; 8 ≥30 2 . Rapid neurological improvement prior study randomization 3 . Female pregnant lactate positive pregnancy test time admission 4 . Taking part another clinical study . 5 . History stroke past 3 month . 6 . Current participation another investigational drug device treatment study . 7 . Uncontrolled hypertension define systolic blood pressure &gt; 185 diastolic blood pressure &gt; 110 control except continuous parenteral antihypertensive medication . 8 . Known hereditary acquire hemorrhagic diathesis , coagulation factor deficiency . ( Patients without history suspicion coagulopathy require INR prothrombin time lab result available prior enrollment . ) 9 . Warfarin therapy INR great 1.7 . 10 . Low molecular Weight Heparins ( Dalteparin , Enoxaparin , Tinzaparin , Fondaparinux ) DVT prophylaxis full dose within last 24 hour screen . 11 . Subject receive heparin direct thrombin inhibitor ( e.g . rivaroxaban , Angiomax™ , argatroban , Refludan™ ) within last 48 hour must normal partial thromboplastin time ( PTT ) eligible . 12 . Subject receive factor Xa inhibitor therapy ( e.g . dabigatran ) within past 24 hour must normal ecarin clotting time eligible . Subject receive factor Xa inhibitor therapy 24 hour ago less 48 hour ago must normal partial thromboplastin time ( PTT ) eligible . 13 . Baseline lab value : glucose &lt; 50 mg/dl &gt; 400 mg/dl , platelet &lt; 100,000 , Hct &lt; 25 . 14 . Renal Failure define serum creatinine &gt; 2.0 Glomerular Filtration Rate [ GFR ] &lt; 30 . 15 . Subject require hemodialysis peritoneal dialysis , contraindication angiogram whatever reason . 16 . Life expectancy le 90 day . 17 . Previous intracranial hemorrhage , neoplasm , subarachnoid hemorrhage , cerebral aneurysm , arteriovenous malformation . 18 . Clinical presentation suggest subarachnoid hemorrhage , even initial CT MRI scan normal . 19 . Presumed septic embolus , suspicion bacterial endocarditis . 20 . Presumed pericarditis include pericarditis acute myocardial infarction . 21 . Suspicion aortic dissection . 22 . Surgery biopsy parenchymal organ within 30 day . 23 . Trauma internal injury ulcerative wound within 30 day . 24 . Severe head trauma head trauma loss consciousness within 90 day . 25 . Any active recent hemorrhage within 30 day . 26 . Cerebral vasculitis . 27 . Subject preexist neurological psychiatric disease would confound neurological functional evaluation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2015</verification_date>
</DOC>